These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 23922322)

  • 1. Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs.
    Toh S; Avorn J; D'Agostino RB; Gurwitz JH; Psaty BM; Rothman KJ; Saag KG; Sturkenboom MC; Vandenbroucke JP; Winterstein AG; Strom BL
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1036-45. PubMed ID: 23922322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction.
    Platt R; Carnahan RM; Brown JS; Chrischilles E; Curtis LH; Hennessy S; Nelson JC; Racoosin JA; Robb M; Schneeweiss S; Toh S; Weiner MG
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():1-8. PubMed ID: 22262586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design considerations, architecture, and use of the Mini-Sentinel distributed data system.
    Curtis LH; Weiner MG; Boudreau DM; Cooper WO; Daniel GW; Nair VP; Raebel MA; Beaulieu NU; Rosofsky R; Woodworth TS; Brown JS
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():23-31. PubMed ID: 22262590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RE: Drug risk assessment and data reuse.
    Toh S; Avorn J; D'Agostino RB; Gurwitz JH; Psaty BM; Rothman KJ; Saag KG; Sturkenboom MC; Vandenbroucke JP; Winterstein AG; Strom BL
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):109-10. PubMed ID: 24395550
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug risk assessment and data reuse.
    Iyasu S; Staffa J; Graham D; Shoaibi A; Levenson M; Chakravarty A; Hammad TA
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):107-8. PubMed ID: 24395549
    [No Abstract]   [Full Text] [Related]  

  • 6. Food and Drug Administration recommends against the continued use of propoxyphene.
    Food And Drug Administration Public Health Service U S Department Of Health And Human Services
    J Pain Palliat Care Pharmacother; 2011; 25(1):80-2. PubMed ID: 21426228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Introduction of U.S. FDA mini-sentinel program].
    Xie YM; Liao X; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Mar; 38(5):768-72. PubMed ID: 23724692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise.
    Nguyen M; Ball R; Midthun K; Lieu TA
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():291-7. PubMed ID: 22262619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Likelihood ratio test-based method for signal detection in drug classes using FDA's AERS database.
    Huang L; Zalkikar J; Tiwari RC
    J Biopharm Stat; 2013; 23(1):178-200. PubMed ID: 23331230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.
    Clark JA; Humphries JE; Crean S; Reynolds MW
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):107-14. PubMed ID: 20014051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The state of dietary supplement adverse event reporting in the United States.
    Gardiner P; Sarma DN; Low Dog T; Barrett ML; Chavez ML; Ko R; Mahady GB; Marles RJ; Pellicore LS; Giancaspro GI
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):962-70. PubMed ID: 18613260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agent.
    Fireman B; Toh S; Butler MG; Go AS; Joffe HV; Graham DJ; Nelson JC; Daniel GW; Selby JV
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():282-90. PubMed ID: 22262618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mini-Sentinel methods: framework for assessment of positive results from signal refinement.
    McClure DL; Raebel MA; Yih WK; Shoaibi A; Mullersman JE; Anderson-Smits C; Glanz JM
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):3-8. PubMed ID: 24395545
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
    Hart B; Lundh A; Bero L
    BMJ; 2012 Jan; 344():d7202. PubMed ID: 22214754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the U.S. Food and Drug Administration in device evaluation and monitoring.
    ; Diehl DL; Tierney WM; Adler DG; Conway JD; Farraye FA; Kantsevoy SV; Kaul V; Kethu SR; Kwon RS; Mamula P; Pedrosa MC; Rodriguez SA
    Gastrointest Endosc; 2010 Jul; 72(1):5-10. PubMed ID: 20421100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Authority of the Food and Drug Administration to require data access and control use rights in the Sentinel data network.
    Evans BJ
    Food Drug Law J; 2010; 65(1):67-112, ii. PubMed ID: 24475535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active surveillance of postmarket medical product safety in the Federal Partners' Collaboration.
    Robb MA; Racoosin JA; Worrall C; Chapman S; Coster T; Cunningham FE
    Med Care; 2012 Nov; 50(11):948-53. PubMed ID: 23047784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of exposure accrual on sequential postmarket evaluations: a simulation study.
    Maro JC; Brown JS
    Pharmacoepidemiol Drug Saf; 2011 Nov; 20(11):1184-91. PubMed ID: 22020903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.